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Spotlight on Transition in Patients With Inflammatory Bowel 
Disease: A Systematic Review
Adrienn Erős, MD,*,† Alexandra Soós, MSc,*,‡ Péter Hegyi, MD, PhD, DSc,*,†,§,¶ Zsolt Szakács, MD,*,† Bálint Erőss, 
MD,*,† Andrea Párniczky, MD, PhD,*,†,‖ Emese Mezősi, MD, PhD, DSc,†,¶ Zoltán Rumbus, MD,*,† and  Patricia 
Sarlós, MD, PhD*,†,¶
Background: Transition of adolescents from pediatric to adult care is of great importance in the management of inflammatory bowel disease 
(IBD). Our aim was to review and summarize the currently applied interventions and outcomes related to transition practices in IBD.
Methods: A systematic review was performed in accordance with the PRISMA Statement. We searched PubMed, EMBASE, CENTRAL, and 
Web of Science databases up to February 15, 2019. Controlled studies evaluating adolescents and young adults with IBD participating in struc-
tured transition interventions or patient educational programs and single-arm (before-after) studies were included. Several individual, health care, 
and social outcomes were assessed. The PROSPERO registration number is CRD42019118520.
Results: A total of 23 articles were eligible for qualitative synthesis. Eleven studies compared an intervention to a control group, whilst 12 
studies were uncontrolled before-after studies. The age of the participants varied from 11 to 25 years. The most common structured transition 
interventions were joint visits and patient education programs. IBD nurses were operating as nominated transition coordinators in the transition 
process. Quality of life, patient satisfaction, self-efficacy, disease-specific knowledge, adherence rate, and nonattendance rate at outpatient clinic 
were identified as main health care transition outcomes besides disease-related outcomes. Despite the various study designs and methodological 
limitations, outcomes improved with the application of structured transition interventions in eleven of the studies.
Conclusion: These results facilitate the design of randomized controlled trials along better standards in transitional care in IBD.
Key Words:  inflammatory bowel disease, transitional care, adolescents, structured transition intervention, patient education program
INTRODUCTION
Transition is defined as a purposeful, planned movement 
of adolescents and young adults suffering from chronic physical 
and medical conditions from child- to adult-orientated health 
care systems.1 Providing transitional care should be considered 
as a complex intervention.2 Recently, nondisease-specific 
studies aimed to determine the corner stones and main out-
comes of the transition process.3,4 In 2015, an international 
Delphi study was carried out to identify the key elements and 
indicators of a successful transition.3 Based on the agreement 
of the panelists, essential and very important elements of a 
successful transitional program were specified (eg, good coor-
dination, early planning, self-management and education, per-
sonalized transition plan, and discussion of risk behaviors). 
The most important indicator was the avoidance of loss of 
follow-up (F/U).3 In another 3-stage Delphi process, quality 
of life was identified as the highest-rated outcome measure be-
sides other individual, health service, and social outcomes (eg, 
disease-specific knowledge, self-management, adherence to 
medication, attendance on medical appointments, and social 
network).4
In recent decades, structured transition interventions 
(STI) have been in the focus in long-lasting conditions, es-
pecially in type 1 diabetes,5 cystic fibrosis,6 congenital heart 
diseases,7 or inflammatory bowel diseases (IBD).8 STI is a 
complex, multidisciplinary intervention designed to provide 
additional support in the transition period.9 Although sev-
eral reviews have been published and recommendations have 
been proposed, there is no gold standard on how to provide 
transitional care in IBD. In the topical review of the European 
Crohn’s and Colitis Organization, based on expert opinion, 
14 practice points were identified as critical elements of tran-
sition programs.10 Accordingly, the ideal model of transition 
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includes a joint pediatric-adult clinic. As for the primary goals 
during the transition process, adolescents should be empowered 
to make decisions, be self-efficacious, and develop disease-
specific knowledge. Education of patients and parents should 
start at least 1 year before transfer. Application of validated 
and adapted tools and questionnaires are recommended for the 
F/U of the success of the targeted interventions. Patient educa-
tion and the maintenance of remission during transfer are also 
highlighted.10
Several pitfalls may occur during the transition, 
disrupting the continuity of medical care and resulting in 
poor long-term outcomes. Failed transition was described in 
chronically ill adolescents, leading to loss of F/U,11 decreased 
adherence,12 poorer disease control,13 and an increased risk of 
disease-related hospitalization.14
To obtain a comprehensive picture about the currently 
applied transition strategies in IBD, this systematic review 
purposed to provide an overview of the applied interventions 
throughout transition in IBD and to test their effect on health 
care transition outcomes related to IBD patient care.
MATERIALS AND METHODS
This systematic review was performed and reported 
in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) state-
ment15 (Supplementary Table 1). The protocol was regis-
tered in the International Prospective Register of Systematic 
Reviews (PROSPERO) under the identification number of 
CRD42019118520.
Search Strategy
An extensive systematic search was conducted in 4 elec-
tronic databases: PubMed (ncbi.nlm.nih.gov/pubmed), Web of 
Science (webofknowledge.com) EMBASE (embase.com), and 
Central Cochrane Register of Controlled Trials (CENTRAL) 
(cochranelibrary.com). The search was last updated on 
February 15, 2019, with the following query combining free-
text terms and Medical Subject Headings: “inflammatory bowel 
disease” OR IBD OR “Crohn disease” OR “ulcerative colitis” 
AND transition*. Additionally, the reference lists of relevant 
articles were reviewed to find relevant records. The search was 
limited to articles in English and human studies.
Eligibility Criteria
Studies conducted on patients with IBD focusing on the 
transition process as an intervention method and assessing 
different outcome measures were eligible for inclusion. Any 
study published as a full-text article or a conference abstract 
was selected if  it (1) examined a population of adolescents or 
young adults with IBD ranging in age between 15 and 20 years 
who were subjected to the transition process, (2) applied STI 
during the period of transition from pediatric to adult care, (3) 
compared the results of an intervention group (IG) to that of 
a control group (CG) consisting of patients with IBD trans-
ferred to the adult gastroenterologist (AGE) with unstructured 
transition process or evaluated the effectiveness of STI with 
before-after design, (4) examined the efficacy of patient edu-
cation programs (PEPs) related to IBD transition process, and 
(5) either reported on the change of individual, health care and 
social outcomes, or the satisfaction and the perceptions of IBD 
patients throughout transition.
Selection and Data Extraction
Search results were imported into a reference man-
agement software (EndNote X8, Clarivate Analytics, 
Philadelphia, PA, USA). First, overlapping records and du-
plicates were removed by one of  the authors (AE). Then the 
potentially eligible records were screened by title and abstract 
independently by 2 authors (AE and PS). Remaining full-text 
articles and abstracts were screened for eligibility (AE and PS). 
Disagreements were resolved by third-party arbitration at any 
stage of  selection (PH).
The following data were extracted from the included ar-
ticles: first author, year and format of publication (full-text 
article/conference abstract), study sites, study design (prospec-
tive/retrospective; randomized/nonrandomized; controlled/un-
controlled), study population, and the number of patients in 
IG and CG. The applied transition process (STI or PEP) was 
described in detail. The number, structure, and location of the 
joint visits, attending members of the multidisciplinary team 
(MDT), and length of the F/U were recorded. The reported 
outcomes were extracted separately for the IG and CGs with 
p values for comparisons (if  available). In the case of uncon-
trolled before-after studies, baseline and postintervention 
results were extracted with p values for the comparison of 
before-after values (if  available).
Quality of Evidence
The GRADE approach16 was applied for the assessment 
of the quality of the evidence for all internationally identi-
fied health care transition outcomes.4 In accordance with the 
Grade Handbook,16 outcomes of interest were tested against 
6 main criteria: study design, risk of bias, indirectness, incon-
sistency, imprecision, and publication bias. At baseline, “high” 
confidence was given for randomized controlled trials, whereas 
“low” confidence was given for any other design. The baseline 
grade was downgraded by 1 level for serious concerns or by 
2 levels for very serious concerns as per the rules and recom-
mendations of the handbook. Finally, the overall quality of the 
evidence for each outcome was graded as “high,” “moderate,” 
“low,” or “very low.”
Grading was first performed independently by 2 of the 
authors (AE and PS), and then disagreements were discussed 
by involving a third party (ZS) to reach a consensus.
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RESULTS
Study Selection
Our electronic literature search identified a total of 2709 
records (PubMed: 404, Web of Science: 934, EMBASE: 1329, 
and CENTRAL: 42), complemented with 6 potentially eligible 
records identified by hand search (PRISMA flow chart; Fig. 1). 
After the removal of duplicates, 1668 articles remained, 1602 
of which were excluded based on title and abstract. According 
to our eligibility criteria, 66 potentially eligible records were as-
sessed for inclusion. During the full-text evaluation, 43 were ex-
cluded: studies not reporting the outcome of interest (n = 23), 
studies without CG, intervention, or detailed data on patients 
with IBD, studies reporting only preliminary results (n = 19), 
and a previously published systematic review (n = 1). Finally, 
23 studies fulfilled the inclusion criteria and were included in 
the qualitative synthesis.
Characteristics of the Studies Included
The studies included were published in the last 10 years, 
13 of which were published as conference abstracts only.17–29 
Eleven studies were conducted outside Europe.18, 22, 24–26, 28–33 
Among the European articles, trials were identified from the 
United Kingdom,20,21,34 Italy,17, 23 Spain,19, 27 France,35 Germany,36, 
37 the Netherlands,38 and Hungary39 (Tables 1 and 2).
The age of the patients in the included studies ranged be-
tween 11 and 25 years, but most patients were between 17 and 
19 years old at the time of the transfer to AGE. The number 
of participants in the studies varied from 1025 to 245.29 In most 
of the trials, the F/U period lasted from 6 months to 2 years 
after transition. The longest F/U period was 6 years (median),27 
whereas the shortest was 1 month for all participants.28
The studies varied in terms of design. However, there re-
mains a lack of strong evidence because only 2 randomized 
studies, published as conference abstracts, have examined the ef-
ficacy of transition and patient education, including a small series 
of patients.22, 28 Six of the included articles had case-control de-
sign,17, 19, 30, 34, 35, 39 4 had cohort design,21,31,36,37 and another 4 had un-
controlled before-after design.18, 20, 25, 38 In 7 studies, we were unable 
to determine the study design.23, 24, 26, 27, 29, 32, 33 Eleven studies com-
pared IG and CG (Table 1).17, 19, 21, 22, 24, 30, 31, 34, 35, 37, 39 Twelve studies 
provided data on transition outcomes of a single group of patients 
before and after the transitional care (Table 2).18, 20, 23, 25–29, 32, 33, 36, 38
Intervention Types
The studies reported a wide variety of transition inter-
ventions; of these, joint visit with PGE and AGE was the most 
FIGURE 1. Flow chart for study selection.
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common type. One of the first studies aiming to examine the ef-
fects of joint visits was conducted in France.35 All patients con-
sidered a single, 1-hour joint medical visit with PGE and AGE 
beneficial, mostly because it was helpful in building up confi-
dence in AGE.35 On average, 2 to 4 visits were arranged before 
the transfer as part of a transition clinic31, 34, 39 or a structured 
transition program.19, 21–23, 25, 27, 28 In the Netherlands, adolescent 
patients visited the transition clinic at least 4 times a year, while 
they also saw the AGE once a year.38
Joint visits were mainly designed to review patients’ his-
tory and disease progression to educate the patient on IBD 
medication and disease management and to discuss short- 
and long-term plans.25, 33, 39 Some transition clinics focused 
on improving communication skills of the adolescents and 
establishing a relationship with the AGE.18, 23, 27, 39 During joint 
visits, the impact of the interventions was controlled by both 
the nurse and the doctor by filling a transition checklist and 
assessing disease-specific knowledge or self-efficacy.23, 31, 33 
Unfortunately, the majority of the abstracts did not provide 
sufficiently detailed data on the joint visits.
In the evaluated studies, joint visits were hosted at var-
ious locations. The joint visit was located either in the usual 
pediatric environment33, 39 or in the adult gastroenterology 
department.38 In the study of Cole et al and Romeo et al, al-
ternating joint visits were held at pediatric and adult gastroen-
terology departments.23, 34
Besides the presence of a PGE and an AGE, other pro-
fessionals also participated as stakeholders at the transition 
clinics. The additional members of the MDT were most often 
IBD nurses,24, 33, 34, 38, 39 dietitians,24, 33, 34 and psychologists.33, 34 In 
few trials, social workers24 and family therapists38 were involved, 
as well.
The other transition intervention methods in the trials 
were PEPs.28, 32, 36, 37 In Germany, the intervention was a 2-day 
workshop held for the adolescent patients with chronic condi-
tions (IBD, type 1 diabetes, and cystic fibrosis) aiming to pro-
vide information about the adult care, coordination of future 
disease management, career choices, and partnership.36, 37 In the 
study of Boamah et al, an interactive multimedia CD-ROM 
was distributed, summarizing different IBD-related topics like 
disease knowledge, symptoms, diagnosis, complications, medi-
cations, nutrition, and social functioning.32 In another study, a 
new guide called “IBD Pocket Guide” supported patients’ med-
ication adherence, IBD knowledge, and transition readiness.28
In 2 studies, the intervention was the involvement of IBD 
nurses in the transition process29, 30 who were functioning as ap-
pointed transition coordinators during transition. In 1 trial, 
the IBD nurse made only an introductory phone call aiming to 
facilitate the arrangement of the first visit with the AGE.30 In 
China, the IBD nurse had a wider range of activities including 
giving instructions to patients in the hospital, visiting patients 
at home, maintaining WeChat groups, and making phone calls 
to promote F/U.29
Measured Outcomes
The measured outcomes substantially varied across 
studies. In our review, we categorized the outcomes based on 
the previously identified international health care transition 
outcome groups.4 Quality of the evidence for each outcome is 
shown in Table 3, with the details of rating by the GRADE ap-
proach16 in Supplementary Table 2.
Individual outcomes
Health-related quality of life as a patient-reported out-
come was examined in 4 studies.21, 23, 29, 37 Scores generated 
with the Short IBD Questionnaire40 and the DISABKIDS 
instruments41 were significantly higher among patients after 
participating in a “transition nursing” program,29 a 2-day 
transition workshop,37 or an STI23 compared with controls. 
Furthermore, Schmidt et al perceived a significant decline in 
the quality of life of the control patients not participating in the 
program.37 In contrast, McCartney et al failed to detect any dif-
ference in the health-related quality of life between the IG and 
CG 2 years after the transition process.21 Scores generated with 
the Anxiety Scale42 and the Work Productivity and Activity 
Index43 were also similar between the 2 groups.21
The level of disease-specific knowledge has been rarely 
evaluated. The IBD-yourself44 and the Crohn’s and Colitis 
Knowledge questionnaires45 were used in 3 before-after 
studies.32,33 In a study from the United States, 21 patients ac-
quired disease-specific knowledge of medications, complica-
tions, and gastrointestinal function thanks to the self-directed 
multimedia education; recollection of the knowledge was suc-
cessful when retesting 9 months later.32 An improvement in the 
specific IBD-yourself  domains, (eg, knowledge of IBD, diag-
nostic tests, and medication use) was also identified in 2 reports 
in which patients completed the transition process.33 In the 
study of Fu et al, similar levels of disease-specific knowledge 
were found in patients who did and did not undergo STI.31
An increasing self-efficacy around self-management was 
confirmed 6 months after the educational intervention36 and 
after the completion of the transition process.29, 33 The German 
version of the General Self-Efficacy Scale,46 chronic disease 
self-management inventory scores,47 and IBD-yourself  ques-
tionnaires44 were applied for outcome assessment.
All studies examining medication adherence as an end-
point28, 30, 31, 34 found better adherence rates among patients 
who underwent STI or PEP compared with CG or the baseline 
values in before-after studies. Fu et al found that patients in 
the IG had significantly stronger beliefs in the necessity of the 
prescribed medications, despite that similar self-reported ad-
herence rates were detected between the cohorts of patients.31
Although the knowledge of health care insurance was 
identified as one of the main outcomes of transition by the 
Delphi process,4 only 1 study assessed this issue. Here, 100% of 
the patients participating in the progressive transition program 
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knew their insurance provider, whereas this rate was only 71% 
in the CG.22
Health service outcomes
Despite the low quality of evidence, STIs can improve pa-
tients’ willingness to attend medical visits. Some studies showed 
that the nonattendance rate at outpatient clinics in the post-
transfer F/U period was higher in patients without STI com-
pared with those receiving STI.24, 34, 38 The rate of successful 
transitions was lowest in the Romeo et al study (40%), mod-
erate in the van den Brink et al study (63%), and highest in 
the Avni-Biron et al study (94%).18, 23, 38 The difference may have 
occurred because diverse types of tools were used for the assess-
ment of successfulness.
Social outcomes
Outcomes related to social network and other social 
functions were examined in only 2 of  the trials included. No 
significant differences were observed between IG and CG 
with respect to social and occupational outcomes (eg, em-
ployment, education, relationship status),30 and socioeco-
nomic status.21
Other outcomes
Patient satisfaction was measured with specific scores 
or on a 10-point Likert scale.17, 19, 22, 25–27 Patients in the IG re-
ceiving STI were significantly more satisfied with the quality of 
the transition process than those in the CG receiving standard 
care.17, 19, 22 Joint medical visits were found beneficial for re-
ceiving enough information about transition.35 Furthermore, in 
the study of Sánchez et al, nearly all of the STI participants 
(94%) achieved a good or a very good “degree of satisfaction” 
after completing the transition program.27
Another outcome was perceived readiness for transition. 
While Dabadie et al found no benefit of the 1-hour joint visit re-
garding transition readiness, Sánchez et al reported that a high 
percentage of patients undergoing STI have received enough in-
formation before transition (84%) and felt adequately prepared 
for transition (78%).27, 35 Moreover, Schmidt et al could detect 
an improvement in the mean score of health-related transition 
competence scale 6 months after the educational program.37
About one-third of the included studies measured outcomes 
related to disease activity, such as the number of IBD-related 
hospital admissions and emergency department visits, need for 
surgery, or treatment modification/escalation.18, 20, 22, 24, 26, 30, 34, 39 
TABLE 3. Categorization of the Measured Outcomes According to the Internationally Identified Health Care 
Transition Outcomes4 and the Quality of the Evidence Assessed According to the GRADE Approach16
Main group of outcomes Specified outcomes Articles investigating the specified outcomes Quality of the evidencea
Individual outcomes - quality of life McCartney et al (2017), Schmidt et al 
(2018), Schmidt et al (2016), Zhu et al 
(2016), Romeo et al (2014)
very low
- understanding the characteris-
tics of the condition
Fu et al (2017), Boamah et al (2010), 
Romeo et al (2014), Ron et al (2015), 
Yerushalmy-Feler et al (2017), Vaz et al 
(2016)
very low
- knowledge of medication Moulton et al (2013), Ron et al (2015), 
Yerushalmy-Feler et al (2017)
very low
- self-management Ron et al (2015), Zhu et al (2016), Schmidt 
et al (2016), Yerushalmy-Feler et al 
(2017), 
very low
- adherence to medication Cole et al (2015), Cole et al (2013), van 
den Brink et al (2018), Yerushalmy-
Feler et al (2017), Vaz et al (2016), Fu et 
al (2017)
very low
- understanding health insurance Moulton et al (2013) very low
Health service outcomes - attending medical appointments Cole et al (2015), Otto et al (2019), 
Williams et al (2017), Cole et al (2013), 
van den Brink et al (2018) 
very low
- having medical home not reported N/A
- avoidance of unnecessary 
hospitalization
not reported N/A
Social outcome - having social network Bennett et al (2016), McCartney et al (2017) very low
aBased on the GRADE approach, for details see also Supplementary Table 2; N/A: nonapplicable.
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Considering these endpoints, no significant difference was 
found between the progressive transition group and the CG 
in the Bennett et al and Moulton et al studies.22, 30 Conversely, 
other studies demonstrated a beneficial impact of STIs on IBD 
outcomes.24, 26, 34, 36, 37, 39 The need for surgery, the hospitalization 
rate,34 and the attendance rate at the emergency department26 
were significantly reduced among patients undergoing STIs 
compared with those in CG. According to Otto et al, signifi-
cantly more patients were in remission 12 months after transfer 
in the IG than in the CG.39
DISCUSSION
The aim of this systematic review was to summarize the 
current transition practices in IBD and to comprehensively as-
sess their effects on transition-related outcomes.
Altogether, 23 studies met our inclusion criteria, only 10 
of which were published as a full-text article. We found a high 
diversity across the studies both in the applied interventions 
and the outcome. The joint visit was the most common form of 
STI, performed solely or as a part of a complex transition pro-
gram. A notable heterogeneity was observed in the number and 
the setting of the performed joint visits. None of the studies 
investigated whether the arrangement of 1 visit is more advan-
tageous over that of multiple visits for adolescents.
Patient education should be a key element in the transition 
process. In our review, PEPs were diverse, including workshops 
and the application of web-based or text-delivered learning ma-
terials.28, 32, 36, 37 The implementation of these programs resulted 
in better disease-specific knowledge, transition competence, 
and medication adherence. Recent guidelines mention informa-
tion technology as a potential tool for facilitating education.48
The MDT is central to the optimal management of IBD 
patients. An MDT dedicated to transition process should con-
sist of a dietician, an IBD nurse, a psychologist, a social worker, 
a family therapist, a PGE, and an AGE.10 To establish a good 
partnership between stakeholders, the continuity of coordina-
tion is mandatory. It seems that the transition is best coordi-
nated by an IBD nurse ensuring the continuity of care.
Recently, the establishment of medical homes came into 
the focus of attention, which target to better adapt health care 
services to the patients’ needs. Having an IBD medical home 
means that patients have continuous access to a well-organized, 
high-quality health care service at a hospital (24/7 service) 
where an MDT is responsible for providing preventive, acute, 
and chronic care.49 Furthermore, mood disturbances, which 
are common among patients with IBD, can contribute to the 
worsening of the disease symptoms.50 Maladaptive cooperation 
with the pain and difficulties caused by IBD may result in unnec-
essary hospitalizations, which could be prevented by involving 
the patients in the decision-making process, by educating them 
on stress reduction and coping techniques, and by securing con-
tinuous medical supervision via telemedicine (either via phone 
or the internet).49 The role of having a medical home and the 
relevance of avoidance of unnecessary hospitalizations were 
not investigated in the studies included at all.
Similarly to the internationally identified health care tran-
sition outcomes, a wide variety of individual, health service, 
and social outcomes were addressed in the studies included.4 
Despite the heterogeneous study designs and methodological 
limitations, 11 of the studies demonstrated that various types 
of transition interventions were favorable. Interestingly, quality 
of life, as considered the most important one among outcomes, 
was measured only in 17% of the studies. In contrast, outcomes 
related to disease activity were assessed in 30% of the studies 
included, despite the fact that these were not even mentioned 
among the top 10 transition outcomes in the literature. For 
the assessment of the impact of interventions, various widely 
accepted and reliable tools were used, such as the Short IBD 
Questionnaire,40 the DISABKIDS,41 the IBD-yourself,44 and 
the General Self-Efficacy Scale.46
However, there is still no clear definition of the term 
“successful transition.” Romeo et al considered the transi-
tion successful if  the patient completed all 3 transition visits.23 
Avni-Biron et al defined successful transition as complete F/U 
throughout the first year with an AGE.18 Van den Brink et al 
used a newly developed, composite score system to evaluate 
the success of transition, which has not yet been validated. The 
Transition Yourself  Score is created by adding several subscores 
(eg, patients’ satisfaction, medication adherence, nonattendance 
rates at outpatient clinic, and time to first outpatient visit to an 
AGE).38 It is notable that all the mentioned studies highlighted 
the importance of the continuity of patient care (ie, uninter-
rupted health care services). Recently in a multinational Delphi 
study, the 3 most important items of successful transition were 
decision-making regarding IBD, independent communication, 
and patient satisfaction.51 Remarkably, self-management skills 
were regarded as more important than IBD-specific items.51
There are several limitations of  the evidence we need to 
mention. Given that the number of  studies conducted on this 
topic is limited, we also included trials published in abstract 
form only. In most of  the abstracts, the detailed features of 
the interventions were not reported, making the comparison 
of  the studies problematic. Instead of  using a risk of  bias 
tool, we attempted to collect the limitations of  the included 
studies in the limitation section of  the article. However, our 
review is also limited by the methodological quality of  in-
cluded studies (mostly observational design), including small 
sample size, trials without appropriate CGs, and the lack of 
randomization. In addition, the tools of  outcome measure-
ment were often not validated (eg, Transition Yourself  Score). 
Most of  the studies were single-centered and did not have the 
required length of  F/U to detect the long-term effects of  the 
interventions. High dropout rates were observed in some of 
the trials, whereas the results of  the pilot surveys were dis-
torted by low response rates and recall bias. Selection bias, 
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the ignorance of  patients’ socioeconomic status, and the sta-
tistically significant differences in clinical characteristics be-
tween the IG and CG groups (eg, disease duration) could also 
have affected the results. Furthermore, language barriers (eg, 
educational material only available in the English language) 
and country-specific transition approaches resulted in limited 
generalizability of  the results. Similar limitations were seen in 
other literature reviews on the field of  transitional care in type 
1 diabetes, cystic fibrosis, and congenital heart disease.52–55
A strength of this systematic review is that data extrac-
tion was performed as comprehensively and as accurately as 
possible. The examined patient population, the number and the 
aim of each joint visit, the core elements of the applied PEPs, 
the lengths of the F/U period, and the measured outcomes were 
collected in detail. To compensate for the lack of risk of bias as-
sessment, all reported limitations of each study were annotated. 
Another strength of our review is that the certainty of the evi-
dence was examined for all international health care transition 
outcomes according to the GRADE approach.16 Based on our 
strict and consistent grading, the quality of the evidence for 
each outcome proved to be very low. These findings highlight 
the lack of high-quality evidence in this field and draw atten-
tion to the urgent need for reliable data related to STIs.
In conclusion, our review suggests that the implemen-
tation of STIs and PEPs in patients with IBD may improve 
patients’ adherence, disease-specific knowledge, willingness to 
attend clinical visits, and self-efficacy and may result in a higher 
level of patient satisfaction. Although there is very little pub-
lished research about long-term health care outcomes after tran-
sition, it can be supposed that patients not lost to F/U will have 
a decreased number of disease-related emergency department 
visits, reduced hospitalization rates, and a less frequent need 
for surgery or therapy escalation. In contrast, not participating 
in a transition process may result in adverse consequences (eg, 
higher rate of hospital admissions due to acute flare-up and/or 
emergency surgeries).34
The complexity of the transition process makes it diffi-
cult to determine which components of the intervention are re-
sponsible for any potential benefit. Therefore, it is important 
for future research to clearly identify these interventions and 
outcomes in detail. Because the quality of evidence proved to 
be very low for each outcome, the results of ongoing studies are 
awaited, and further trials are needed to determine the best set-
ting and the long-term impact of these interventions.
SUPPLEMENTARY DATA
Supplementary data is available at Inflammatory Bowel 
Diseases online.
Supplementary Table 1. PRISMA Checklist for Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses.
Supplementary Table 2. Investigation of Quality of the 
Evidence for All Included Outcomes (GRADE).
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